<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To investigate the immunophenotypes of primary nasopharyngeal non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NPL) and their relationship to Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The clinical data and biopsies of 73 patients with NPL were collected in Guangzhou </plain></SENT>
<SENT sid="2" pm="."><plain>In situ hybridization was performed to detect the EBV-encoded small non-polyadenylated nuclear <z:chebi fb="40" ids="33697">RNAs</z:chebi> (EBERs) on biopsy slides </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry was used to classify the immunophenotypes of NPL and detect EBV antigen expression </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Forty-four (60.27%) of the 73 NPLs were of B cell lineage (CD79alpha(+)/CD3(-)/CD56(-)) while the 29 others (39.73%) were of non-B cell lineage </plain></SENT>
<SENT sid="5" pm="."><plain>Seventy-three NPLs could be classified into 3 major immunophenotypes: B cell (CD79alpha(+)/CD3(-)/CD56(-), 44 cases), peripheral T cell (CD79alpha(-)/CD3(+)/CD56(-), 22) and NK/T cell (CD79alpha(-)/CD3(+)/CD56(+), 7) </plain></SENT>
<SENT sid="6" pm="."><plain>The percentages of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> differed among the 3 major immunophenotypes (B cell: 11.36%, 5/44; peripheral T cell: 81.82%, 18/22; NK/T cell: 100%, 7/7) </plain></SENT>
<SENT sid="7" pm="."><plain>Both CD56(-) positive and CD56(-) negative immunophenotypes could further be divided into 4 subtypes: CD8(-)/CD4(-), CD8(+)/CD4(-), CD8(-)/CD4(+) and CD8(+)/CD4(+) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the CD8(-)/CD4(-) NPLs with CD56(-) positivity (7) or CD56(-) negativity (2) were infected with EBV </plain></SENT>
<SENT sid="9" pm="."><plain>The neoplastic cells of a nasopharyngeal Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> expressed EBV nuclear antigen 1 (EBNA1) and EBV <z:chebi fb="40" ids="33697">RNA</z:chebi> (EBERs) only </plain></SENT>
<SENT sid="10" pm="."><plain>In the other 29 EBV-infected NPLs, most of the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells harboring EBV also expressed EBNA1 and EBERs; 21 of the 29 NPLs had a considerable number of neoplastic cells expressing latent membrane protein 1 (LMP1) (21/29, 72.41%) and 23 of 29 NPLs expressed latent membrane protein 2A (LMP2A) (23/29, 79.31%) </plain></SENT>
<SENT sid="11" pm="."><plain>A few <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells in 17 (17/29, 58.62%), 23 (23/29, 79.31%) and 22 NPLs (22/29, 75.86%) expressed Zta (Bam HI Z transactivator), <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA) and membrane antigen (MA), respectively </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The prevalence ratio of the 3 immunophenotypes, namely, B cell, peripheral T cell and NK/T cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, is about 6:3:1 </plain></SENT>
<SENT sid="13" pm="."><plain>However, the <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> ratio is reversed, 1:8:10 </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the NK/T cell (CD56(+)) and peripheral immature T cell (CD3(+)/CD8(-)/CD4(-)) NPLs were EBV-infected </plain></SENT>
<SENT sid="15" pm="."><plain>Except for one Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the EBV harbored in both B cell and non-B cell NPLs was mainly <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e>, type II, expressing EBNA1, LMP1 and LMP2A </plain></SENT>
<SENT sid="16" pm="."><plain>However, the EBV found in a few <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells could become replicative, expressing lytic proteins </plain></SENT>
</text></document>